Prof. Dr. Seppo Yla-Herttuala
The PhD student (DC1) will be enrolled in the Doctoral Program of Molecular Medicine at the University of Eastern Finland.
This PhD student will study inflammatory cells, gene expression profiles and their role in the pathogenesis and new treatment options for atherosclerosis and ischemic diseases. Special emphasis will be put on the development of targeted gene therapy-based approaches for the treatment of vascular diseases. Both in vitro cell culture models and in vivo mouse and pig models will be used for the studies. Additionally, DC will be involved in gene expression profiling and spatial transcriptomic analyses of mouse and human atherosclerotic lesions.
COLLABORATORS AND SECONDMENTS IN THIS PHD PROJECT
ABOUT A.I.Virtanen Institute, University of Eastern Finland
The University of Eastern Finland (UEF) is the most multidisciplinary university in Finland. Our university employs approximately 3,200 experts, and our community includes approximately 16,000 degree students and 16,000 adult education students. We represent the world’s cutting edge of research in atherogenesis, angiogenesis, genetics, animal models and gene therapy, and produce research-based knowledge for the prevention and treatment of cardiovascular diseases. Learn more about our university at www.uef.fi/en. The available position is located in Kuopio, a city which embodies the ideal mix of urban and natural environments. Home to roughly 123,000 inhabitants, it's a city where safety, functionality, and the beauty of nature contribute to a high-quality living standard, perfectly balancing work, study, and leisure.
ABOUT THE SUPERVISORS
Prof. Seppo Yla-Herttuala, Docent Nihay Laham-Karam, Dr Petri Mäkinen and Dr Anna-Kaisa Ruotsalainen from the Molecular Medicine group at the A.I. Virtanen Institute will supervise the DC at UEF.
Prof. Dr. Seppo Yla-Herttuala